Ocular allergy/inflammation:

Indications for: BROMSITE

Post-operative inflammation and prevention of ocular pain following cataract surgery.

Adult Dosage:

≥18yrs: 1 drop in affected eye twice daily starting 1 day before surgery, continued on day of surgery, and for 14 days post-op. May be given with other topical ophthalmics (eg, alpha-agonists, beta-blockers, carbonic anhydrase inhibitors, cycloplegics, mydriatics); administer at least 5 mins apart.

Children Dosage:

<18yrs: not established.

BROMSITE Warnings/Precautions:

Bleeding tendencies. May slow or delay wound healing. Potential for cross-sensitivity to acetylsalicylic acid, phenylacetic acid derivatives, other NSAIDs. Complicated/repeat ocular surgeries. Corneal defects/denervation. Ocular surface diseases. Rheumatoid arthritis. Diabetes. Monitor cornea; discontinue if corneal epithelial breakdown occurs. Risk of corneal adverse events may be increased if used >24hrs before surgery, or beyond 14-days post-op. Contact lenses (remove during therapy). Pregnancy: avoid during late pregnancy. Nursing mothers.

BROMSITE Classification:


BROMSITE Interactions:

Concomitant topical NSAIDs and corticosteroids may potentiate healing problems. Caution with concomitant drugs that prolong bleeding time.

Adverse Reactions:

Anterior chamber inflammation, headache, vitreous floaters, iritis, eye pain, ocular hypertension; keratitis, corneal reactions (eg, epithelial breakdown, thinning, erosion, ulceration/perforation).

Generic Drug Availability:


How Supplied: